{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:32:24Z","timestamp":1787841144458,"version":"build-2784847793"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["530690968"],"award-info":[{"award-number":["530690968"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["493400536"],"award-info":[{"award-number":["493400536"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["413659045"],"award-info":[{"award-number":["413659045"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["510844896"],"award-info":[{"award-number":["510844896"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pharmthera.2024.108747","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T19:22:20Z","timestamp":1730575340000},"page":"108747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Lipoprotection in cardiovascular diseases"],"prefix":"10.1016","volume":"264","author":[{"given":"Marcel","family":"Benkhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Polzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2024.108747_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/303456","article-title":"The role of long-chained marine N-3 polyunsaturated fatty acids in cardiovascular disease","volume":"2012","author":"Aarsetoey","year":"2012","journal-title":"Cardiology Research and Practice"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0010","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1111\/bph.14463","article-title":"Successful treatment of established heart failure in mice with recombinant HDL (Milano)","volume":"175","author":"Aboumsallem","year":"2018","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061273","article-title":"Effective treatment of diabetic cardiomyopathy and heart failure with reconstituted HDL (Milano) in mice","volume":"20","author":"Aboumsallem","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0020","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jnutbio.2009.12.004","article-title":"Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids","volume":"21","author":"Adkins","year":"2010","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0025","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/RHU.0000000000000563","article-title":"Omega-3 fatty acids in rheumatic diseases: A critical review","volume":"23","author":"Akbar","year":"2017","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106487","article-title":"High density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists","volume":"9","author":"Al-Jarallah","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18092012","article-title":"Selective HDL-raising human Apo A-I gene therapy counteracts cardiac hypertrophy, reduces myocardial fibrosis, and improves cardiac function in mice with chronic pressure overload","volume":"18","author":"Amin","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.15171\/jcvtr.2015.12","article-title":"Effects of Ramadan fasting on serum amyloid a and protein carbonyl group levels in patients with cardiovascular diseases","volume":"7","author":"Asadi","year":"2015","journal-title":"J Cardiovasc Thorac Res"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"290","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0050","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/jphp.12744","article-title":"Omega-3 fatty acids in prevention of diabetic retinopathy","volume":"69","author":"Behl","year":"2017","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0055","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/bph.15336","article-title":"Omega-3 polyunsaturated fatty acids and hypertension: A review of vasodilatory mechanisms of docosahexaenoic acid and eicosapentaenoic acid","volume":"178","author":"Bercea","year":"2021","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with Icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0065","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1161\/01.CIR.0000070934.69310.1A","article-title":"Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein","volume":"107","author":"Bisoendial","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0070","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jchf.2019.03.008","article-title":"Predicting risk for incident heart failure with Omega-3 fatty acids: From MESA","volume":"7","author":"Block","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1203859","article-title":"n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia","volume":"367","author":"Bosch","year":"2012","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0080","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Bowman","year":"2017","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0085","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1804989","article-title":"Effects of n-3 fatty acid supplements in diabetes mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0090","author":"Bozkurt","year":"2021","journal-title":"Journal of Cardiac Failure"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0095","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.113.002659","article-title":"\u03b21-adrenergic receptor and sphingosine-1-phosphate receptor 1 (S1PR1) reciprocal downregulation influences cardiac hypertrophic response and progression to heart failure: Protective role of S1PR1 cardiac gene therapy","volume":"128","author":"Cannavo","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16183329","article-title":"Decrease in HDL-C is associated with age and household income in adults from the Korean National Health and nutrition examination survey 2017: Correlation analysis of low HDL-C and poverty","volume":"16","author":"Cho","year":"2019","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vph.2016.01.005","article-title":"Short term omega-3 polyunsaturated fatty acid supplementation induces favorable changes in right ventricle function and diastolic filling pressure in patients with chronic heart failure; A randomized clinical trial","volume":"79","author":"Chrysohoou","year":"2016","journal-title":"Vascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0110","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1002\/jcp.30235","article-title":"The antithetic role of ceramide and sphingosine-1-phosphate in cardiac dysfunction","volume":"236","author":"Cirillo","year":"2021","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0115","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/01.ATV.15.11.1987","article-title":"High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules","volume":"15","author":"Cockerill","year":"1995","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0120","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","article-title":"Temporal trends and patterns in heart failure incidence: A population-based study of 4 million individuals","volume":"391","author":"Conrad","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0125","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1055\/s-0040-1701205","article-title":"Determinants of serum- and plasma Sphingosine-1-phosphate concentrations in a healthy study group","volume":"4","author":"Daum","year":"2020","journal-title":"TH Open"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0130","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJM199704103361502","article-title":"Fish consumption and the 30-year risk of fatal myocardial infarction","volume":"336","author":"Daviglus","year":"1997","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105564","article-title":"Exosomes from adipose-derived mesenchymal stem cells ameliorate cardiac damage after myocardial infarction by activating S1P\/SK1\/S1PR1 signaling and promoting macrophage M2 polarization","volume":"114","author":"Deng","year":"2019","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.lfs.2018.01.023","article-title":"Sphingosine-1-phosphate (S1P) activates STAT3 to protect against de novo acute heart failure (AHF)","volume":"196","author":"Deshpande","year":"2018","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0002-8703(03)00118-2","article-title":"Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate","volume":"146","author":"Deutschman","year":"2003","journal-title":"American Heart Journal"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0150","first-page":"2499","article-title":"Lipid-related markers and cardiovascular disease prediction","volume":"307","author":"Di Angelantonio","year":"2012","journal-title":"Jama"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/cvr\/cvn087","article-title":"Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate","volume":"79","author":"Due\u00f1as","year":"2008","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0160","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1042\/BCJ20170703","article-title":"High-density lipoprotein protects cardiomyocytes against necrosis induced by oxygen and glucose deprivation through SR-B1, PI3K, and AKT1 and 2","volume":"475","author":"Durham","year":"2018","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0165","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(79)91490-9","article-title":"Haemostatic function and platelet polyunsaturated fatty acids in Eskimos","volume":"2","author":"Dyerberg","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0170","first-page":"5","article-title":"The prognostic impact of HDL-C level in patients presenting with ST-elevation myocardial infarction","volume":"30","author":"El Amrawy","year":"2023","journal-title":"British Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0175","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019123","article-title":"Impaired high-density lipoprotein function in patients with heart failure","volume":"10","author":"Emmens","year":"2021","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.arcmed.2017.03.013","article-title":"Sphingosine 1-phosphate postconditioning protects against myocardial ischemia\/reperfusion injury in rats via mitochondrial signaling and Akt-Gsk3\u03b2 phosphorylation","volume":"48","author":"Fang","year":"2017","journal-title":"Archives of Medical Research"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-2275(20)39898-9","article-title":"Molecular physiology of reverse cholesterol transport","volume":"36","author":"Fielding","year":"1995","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2013.02.003","article-title":"HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity","volume":"228","author":"Frias","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0195","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease","volume":"299","author":"Frikke-Schmidt","year":"2008","journal-title":"Jama"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/ATVBAHA.121.317181","article-title":"Pharmacological inhibition of CETP (cholesteryl ester transfer protein) increases HDL (high-density lipoprotein) that contains ApoC3 and other HDL subspecies associated with higher risk of coronary heart disease","volume":"42","author":"Furtado","year":"2022","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0205","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJMoa2400969","article-title":"Apolipoprotein A1 infusions and cardiovascular outcomes after acute myocardial infarction","volume":"390","author":"Gibson","year":"2024","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbalip.2005.08.003","article-title":"High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli","volume":"1736","author":"Gomaraschi","year":"2005","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0735-1097(99)00548-3","article-title":"Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia","volume":"35","author":"Goodfellow","year":"2000","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0220","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0225","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.lfs.2007.06.021","article-title":"The protective effect of ApolipoproteinA-I on myocardial ischemia-reperfusion injury in rats","volume":"81","author":"Gu","year":"2007","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0230","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fcvm.2019.00150","article-title":"An update on the multifaceted roles of STAT3 in the heart","volume":"6","author":"Harhous","year":"2019","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0235","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the Management of Heart Failure: A report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0240","first-page":"2013","article-title":"Aging affects high-density lipoprotein composition and function","volume":"1442-1448","author":"Holzer","year":"1831","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ihj.2024.01.014","article-title":"Association of LDL-C\/HDL-C ratio with coronary heart disease: A meta-analysis","author":"Hu","year":"2024","journal-title":"Indian Heart Journal"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0250","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.biochem.73.011303.073731","article-title":"Lysophospholipid receptors: Signaling and biology","volume":"73","author":"Ishii","year":"2004","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0255","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cardfail.2007.01.007","article-title":"Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure","volume":"13","author":"Iwaoka","year":"2007","journal-title":"Journal of Cardiac Failure"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0260","series-title":"Elsevier science","author":"Jonas","year":"2008"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104793","article-title":"Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology","volume":"156","author":"Jozefczuk","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0270","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/CIRCULATIONAHA.120.052209","article-title":"Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction: A randomized, controlled trial","volume":"143","author":"Kalstad","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0275","article-title":"Therapeutic effects of specialized pro-resolving lipids mediators on cardiac fibrosis via NRF2 activation","volume":"9","author":"Kang","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0280","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCRESAHA.110.235028","article-title":"Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte\/macrophages in inflammation and atherosclerosis","volume":"108","author":"Keul","year":"2011","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0285","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003393","article-title":"Sphingosine-1-phosphate receptor 1 regulates cardiac function by modulating Ca2+ sensitivity and Na+\/H+ exchange and mediates protection by ischemic preconditioning","volume":"5","author":"Keul","year":"2016","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0290","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/01.ATV.0000079011.67194.5A","article-title":"High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors","volume":"23","author":"Kimura","year":"2003","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0295","doi-asserted-by":"crossref","first-page":"37457","DOI":"10.1074\/jbc.M605823200","article-title":"Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells","volume":"281","author":"Kimura","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0300","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2478\/v10039-011-0057-4","article-title":"Decreased free sphingoid base concentration in the plasma of patients with chronic systolic heart failure","volume":"57","author":"Knapp","year":"2012","journal-title":"Advances in Medical Sciences"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0305","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0310","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jacc.2016.08.038","article-title":"High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions: The CANHEART study","volume":"68","author":"Ko","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-09665-0_1","article-title":"Structure of HDL: Particle subclasses and molecular components","volume":"224","author":"Kontush","year":"2015","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0320","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1003603","article-title":"n-3 fatty acids and cardiovascular events after myocardial infarction","volume":"363","author":"Kromhout","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0325","article-title":"Serial circulating omega 3 polyunsaturated fatty acids and healthy ageing among older adults in the cardiovascular health study: Prospective cohort study","volume":"363","author":"Lai","year":"2018","journal-title":"Bmj"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0330","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0335","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejphar.2016.11.004","article-title":"Participation of potassium channels in the antinociceptive effect of docosahexaenoic acid in the rat formalin test","volume":"793","author":"Landa-Ju\u00e1rez","year":"2016","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0340","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jacc.2009.02.084","article-title":"Omega-3 polyunsaturated fatty acids and cardiovascular diseases","volume":"54","author":"Lavie","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0345","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7091-1511-4_8","article-title":"Cardiovascular effects of sphingosine-1-phosphate (S1P)","volume":"147-170","author":"Levkau","year":"2013","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0350","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fphar.2015.00243","article-title":"HDL-S1P: Cardiovascular functions, disease-associated alterations, and therapeutic applications","volume":"6","author":"Levkau","year":"2015","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0355","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0360","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.RES.0000170946.56981.5c","article-title":"New insights into the regulation of HDL metabolism and reverse cholesterol transport","volume":"96","author":"Lewis","year":"2005","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0365","article-title":"Implications of sphingolipids on aging and age-related diseases","volume":"2","author":"Li","year":"2021","journal-title":"Frontiers in Aging"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0370","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/jcmm.12567","article-title":"High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K\/Akt pathway","volume":"19","author":"Lin","year":"2015","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0375","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0380","doi-asserted-by":"crossref","first-page":"15308","DOI":"10.1038\/s41598-021-94052-4","article-title":"Sphingosine-1-phosphate modulates PAR1-mediated human platelet activation in a concentration-dependent biphasic manner","volume":"11","author":"Liu","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0385","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2019","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0390","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","article-title":"Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: Two prospective cohort studies","volume":"38","author":"Madsen","year":"2017","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0395","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1161\/CIRCULATIONAHA.112.107797","article-title":"Sphingosine 1-phosphate as a therapeutic target in heart failure: More questions than answers","volume":"125","author":"Mann","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0400","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1811403","article-title":"Marine n-3 fatty acids and prevention of cardiovascular disease and cancer","volume":"380","author":"Manson","year":"2019","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0405","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/CIRCRESAHA.123.323826","article-title":"Rewiring endothelial sphingolipid metabolism to favor S1P over ceramide protects from coronary atherosclerosis","volume":"134","author":"Manzo","year":"2024","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0410","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","article-title":"Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico (GISSI)-Prevenzione","volume":"105","author":"Marchioli","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0415","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40292-023-00617-x","article-title":"Impact of lipids and vascular damage on early atherosclerosis in adolescents with parental premature coronary artery disease","volume":"31","author":"Mart\u00ednez-Alvarado","year":"2024","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0420","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0425","doi-asserted-by":"crossref","first-page":"H2944","DOI":"10.1152\/ajpheart.01331.2006","article-title":"Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury","volume":"292","author":"Means","year":"2007","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0430","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.111.047316","article-title":"Tumor necrosis factor-\u03b1-mediated downregulation of the cystic fibrosis transmembrane conductance regulator drives pathological sphingosine-1-phosphate signaling in a mouse model of heart failure","volume":"125","author":"Meissner","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0435","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1242\/dev.094805","article-title":"Sphingosine 1-phosphate signalling","volume":"141","author":"Mendelson","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2017.01.001","article-title":"Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application","volume":"66","author":"Messamore","year":"2017","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0445","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/s41598-020-65255-y","article-title":"Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension","volume":"10","author":"Mishra","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/nu16050653","article-title":"High-density lipoprotein metabolism and function in cardiovascular diseases: What about aging and diet effects?","volume":"16","author":"Morvaridzadeh","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0455","doi-asserted-by":"crossref","first-page":"C920","DOI":"10.1152\/ajpcell.00029.2014","article-title":"Sphingosine kinase 1 (Sphk1) negatively regulates platelet activation and thrombus formation","volume":"307","author":"M\u00fcnzer","year":"2014","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0460","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/ATVBAHA.111.226258","article-title":"Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation","volume":"31","author":"Murphy","year":"2011","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0465","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/ATVBAHA.118.310946","article-title":"Hepatocyte-specific SR-BI gene transfer corrects cardiac dysfunction in Scarb1-deficient mice and improves pressure overload-induced cardiomyopathy","volume":"38","author":"Muthuramu","year":"2018","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0470","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/joim.13442","article-title":"Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial","volume":"291","author":"Myhre","year":"2022","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0475","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.freeradbiomed.2006.07.006","article-title":"Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells","volume":"41","author":"Negre-Salvayre","year":"2006","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0480","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose Omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: The STRENGTH randomized clinical trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0485","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCRESAHA.120.316711","article-title":"Endothelial S1P(1) signaling counteracts infarct expansion in ischemic stroke","volume":"128","author":"Nitzsche","year":"2021","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0490","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200418004","article-title":"HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3","volume":"113","author":"Nofer","year":"2004","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0495","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yjmcc.2016.12.003","article-title":"\u03c93-polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4","volume":"103","author":"O\u2019Connell","year":"2017","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182329","article-title":"Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6","volume":"12","author":"Ohkura","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0505","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.clnu.2018.04.017","article-title":"Effects of omega-3 polyunsaturated fatty acids on fibrosis, endothelial function and myocardial performance, in ischemic heart failure patients","volume":"38","author":"Oikonomou","year":"2019","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0510","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/nrcardio.2014.189","article-title":"Heart failure: Mitochondrial dysfunction and oxidative stress in CHF","volume":"12","author":"Okonko","year":"2015","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0515","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.yjmcc.2017.07.004","article-title":"Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease","volume":"110","author":"Polzin","year":"2017","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0520","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ehf2.14176","article-title":"Sphingosine-1-phosphate improves outcome of no-reflow acute myocardial infarction via sphingosine-1-phosphate receptor 1","volume":"10","author":"Polzin","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0525","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/s41467-023-38069-5","article-title":"Revealing concealed cardioprotection by platelet Mfsd2b-released S1P in human and murine myocardial infarction","volume":"14","author":"Polzin","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0530","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12933-017-0523-9","article-title":"Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes","volume":"16","author":"Poreba","year":"2017","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0535","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12933-018-0672-5","article-title":"Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease","volume":"17","author":"Poreba","year":"2018","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0540","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/cvr\/cvu136","article-title":"Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P)","volume":"103","author":"Pot\u00ec","year":"2014","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0545","doi-asserted-by":"crossref","first-page":"46642","DOI":"10.1038\/srep46642","article-title":"Serum concentration of HDL particles predicts mortality in acute heart failure patients","volume":"7","author":"Poto\u010dnjak","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0550","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","article-title":"HDL and cardiovascular disease","volume":"384","author":"Rader","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0555","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1212\/WNL.0000000000005345","article-title":"Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of neurology","volume":"90","author":"Rae-Grant","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0560","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/ATVBAHA.116.308435","article-title":"High-density lipoprotein-associated apolipoprotein M limits endothelial inflammation by delivering Sphingosine-1-phosphate to the Sphingosine-1-phosphate receptor 1","volume":"37","author":"Ruiz","year":"2017","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0565","doi-asserted-by":"crossref","first-page":"H599","DOI":"10.1152\/ajpheart.00314.2021","article-title":"Sphingosine-1-phosphate interactions in the spleen and heart reflect extent of cardiac repair in mice and failing human hearts","volume":"321","author":"S","year":"2021","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20164025","article-title":"Marine-derived omega-3 polyunsaturated fatty acids and heart failure: Current understanding for basic to clinical relevance","volume":"20","author":"Sakamoto","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0575","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00395-010-0112-5","article-title":"Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease","volume":"105","author":"Sattler","year":"2010","journal-title":"Basic Research in Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0580","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000362993","article-title":"HDL-bound sphingosine 1-phosphate (S1P) predicts the severity of coronary artery atherosclerosis","volume":"34","author":"Sattler","year":"2014","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0585","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jacc.2015.07.057","article-title":"Defects of high-density lipoproteins in coronary artery disease caused by low Sphingosine-1-phosphate content: Correction by Sphingosine-1-phosphate-loading","volume":"66","author":"Sattler","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0590","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004169","article-title":"Impaired high-density lipoprotein anti-oxidative function is associated with outcome in patients with chronic heart failure","volume":"5","author":"Schrutka","year":"2016","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0595","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.ajcnut.2023.03.024","article-title":"Replacement of dietary saturated with unsaturated fatty acids is associated with beneficial effects on lipidome metabolites: A secondary analysis of a randomized trial","volume":"117","author":"Sellem","year":"2023","journal-title":"The American Journal of Clinical Nutrition"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0600","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/2047487315610662","article-title":"Is high high-density lipoprotein cholesterol beneficial for premature coronary heart disease? A meta-analysis","volume":"23","author":"Shahid","year":"2016","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0605","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-food-111317-095850","article-title":"Omega-3 polyunsaturated fatty acids and their health benefits","volume":"9","author":"Shahidi","year":"2018","journal-title":"Annual Review of Food Science and Technology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0610","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijcard.2011.10.081","article-title":"Effects of \u03a9-3 fatty acids on endothelial function, arterial wall properties, inflammatory and fibrinolytic status in smokers: A cross over study","volume":"166","author":"Siasos","year":"2013","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0615","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.atherosclerosis.2018.02.030","article-title":"Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: A randomized, double-blind, placebo-controlled study (Omega-FMD)","volume":"271","author":"Siniarski","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168302","article-title":"Serum-Sphingosine-1-phosphate concentrations are inversely associated with atherosclerotic diseases in humans","volume":"11","author":"Soltau","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0625","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1074\/jbc.R600028200","article-title":"Functions of the multifaceted family of sphingosine kinases and some close relatives","volume":"282","author":"Spiegel","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0630","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12950-016-0131-6","article-title":"Apolipoprotein A-I gene transfer exerts immunomodulatory effects and reduces vascular inflammation and fibrosis in ob\/ob mice","volume":"13","author":"Spillmann","year":"2016","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0635","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1161\/ATVBAHA.119.312880","article-title":"Reciprocal multifaceted interaction between HDL (high-density lipoprotein) and myocardial infarction","volume":"39","author":"Sposito","year":"2019","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0640","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/cvr\/cvp312","article-title":"S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species","volume":"85","author":"Takuwa","year":"2010","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0645","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.atherosclerosis.2014.10.011","article-title":"Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanese patients with dyslipidemia","volume":"237","author":"Tanaka","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0650","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1161\/01.CIR.100.17.1816","article-title":"Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice","volume":"100","author":"Tangirala","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0655","doi-asserted-by":"crossref","first-page":"H1022","DOI":"10.1152\/ajpheart.00902.2009","article-title":"High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate","volume":"298","author":"Tao","year":"2010","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0660","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0665","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/imm.12638","article-title":"High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation","volume":"149","author":"Thacker","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0670","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/CIRCULATIONAHA.105.607135","article-title":"High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia\/reperfusion injury in vivo via the S1P3 lysophospholipid receptor","volume":"114","author":"Theilmeier","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0675","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2023.06.025","article-title":"Mortality trends after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction","volume":"82","author":"Thrane","year":"2023","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0680","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/bph.12174","article-title":"HDL and endothelial protection","volume":"169","author":"Tran-Dinh","year":"2013","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0685","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/01.ATV.0000216600.37436.cf","article-title":"High-density lipoproteins enhance progenitor-mediated endothelium repair in mice","volume":"26","author":"Tso","year":"2006","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0690","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/CIRCRESAHA.115.306901","article-title":"Sphingosine 1-phosphate produced by sphingosine kinase 2 intrinsically controls platelet aggregation in vitro and in vivo","volume":"117","author":"Urtz","year":"2015","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0695","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2022.112074","article-title":"S1P lyase inhibition prevents lung injury following high pressure-controlled mechanical ventilation in aging mice","volume":"173","author":"Valentine","year":"2023","journal-title":"Experimental Gerontology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0705","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.107.710830","article-title":"Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy","volume":"117","author":"Van Linthout","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0710","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.109.830984","article-title":"Relations of lipid concentrations to heart failure incidence: The Framingham heart study","volume":"120","author":"Velagaleti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0715","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0720","doi-asserted-by":"crossref","first-page":"E756","DOI":"10.1152\/ajpendo.00549.2013","article-title":"Sphingosine kinase 1 regulates adipose proinflammatory responses and insulin resistance","volume":"306","author":"Wang","year":"2014","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0725","article-title":"Essential polyunsaturated fatty acids in blood from patients with and without catheter-proven coronary artery disease","volume":"23","author":"Wang","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0730","article-title":"Sphingosine-1-phosphate signaling in cardiovascular diseases","volume":"13","author":"Wang","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0735","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jjcc.2017.07.007","article-title":"A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins","volume":"70","author":"Watanabe","year":"2017","journal-title":"Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0740","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","article-title":"Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction","volume":"67","author":"Westman","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0745","doi-asserted-by":"crossref","first-page":"M252","DOI":"10.1093\/geronj\/49.6.M252","article-title":"Determinants of change in total cholesterol and HDL-C with age: The Framingham study","volume":"49","author":"Wilson","year":"1994","journal-title":"Journal of Gerontology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0750","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.123.064296","article-title":"Childhood non-HDL cholesterol and LDL cholesterol and adult atherosclerotic cardiovascular events","volume":"149","author":"Wu","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0755","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12944-020-01262-2","article-title":"U-shaped association between plasma sphingosine-1-phosphate levels and mortality in patients with chronic systolic heart failure: A prospective cohort study","volume":"19","author":"Xue","year":"2020","journal-title":"Lipids in Health and Disease"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0760","first-page":"7664290","article-title":"Sphingosine 1-phosphate-upregulated COX-2\/PGE(2) system contributes to human cardiac fibroblast apoptosis: Involvement of MMP-9-dependent transactivation of EGFR cascade","volume":"2022","author":"Yang","year":"2022","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0765","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13121175","article-title":"Sex-specific relationships between HDL-cholesterol levels and 10-year mortality in individuals with atherosclerotic cardiovascular disease: A Nationwide cohort study of South Koreans","volume":"13","author":"Yang","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0770","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/ije\/dyaa243","article-title":"High-density lipoprotein cholesterol and all-cause mortality by sex and age: A prospective cohort study among 15.8 million adults","volume":"50","author":"Yi","year":"2021","journal-title":"International Journal of Epidemiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0775","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/HYPERTENSIONAHA.110.162719","article-title":"Sphingosine-1-phosphate-induced inflammation involves receptor tyrosine kinase transactivation in vascular cells: Upregulation in hypertension","volume":"57","author":"Yogi","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0780","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0785","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.clnu.2020.05.034","article-title":"Omega-3 polyunsaturated fatty acid supplementation improves lipid metabolism and endothelial function by providing a beneficial eicosanoid-pattern in patients with acute myocardial infarction: A randomized, controlled trial","volume":"40","author":"Yuan","year":"2021","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0790","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/svn-2022-001668","article-title":"Associations of HDL-C\/LDL-C with myocardial infarction, all-cause mortality, haemorrhagic stroke and ischaemic stroke: A longitudinal study based on 384 093 participants from the UK Biobank","volume":"8","author":"Yuan","year":"2023","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0795","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2016.12.008","article-title":"Selective coupling of the S1P(3) receptor subtype to S1P-mediated RhoA activation and cardioprotection","volume":"103","author":"Yung","year":"2017","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108747_bb0800","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017401","article-title":"Plasma Omega-3 fatty acids and the risk of cardiovascular events in patients after an acute coronary syndrome in MERLIN-TIMI 36","volume":"10","author":"Zelniker","year":"2021","journal-title":"Journal of the American Heart Association"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725824001670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725824001670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:46:09Z","timestamp":1733532369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725824001670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":160,"alternative-id":["S0163725824001670"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108747","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotection in cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108747"}}